These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 28703809)
1. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809 [TBL] [Abstract][Full Text] [Related]
2. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea. Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204 [TBL] [Abstract][Full Text] [Related]
3. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018 [TBL] [Abstract][Full Text] [Related]
4. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea. Bhatta P; Dhukhwa A; Sheehan K; Al Aameri RFH; Borse V; Ghosh S; Sheth S; Mamillapalli C; Rybak L; Ramkumar V; Mukherjea D Sci Rep; 2019 Mar; 9(1):4131. PubMed ID: 30858408 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate. Schmitt NC; Rubel EW; Nathanson NM J Neurosci; 2009 Mar; 29(12):3843-51. PubMed ID: 19321781 [TBL] [Abstract][Full Text] [Related]
6. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492 [TBL] [Abstract][Full Text] [Related]
7. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss. Mukherjea D; Jajoo S; Sheehan K; Kaur T; Sheth S; Bunch J; Perro C; Rybak LP; Ramkumar V Antioxid Redox Signal; 2011 Mar; 14(6):999-1010. PubMed ID: 20712533 [TBL] [Abstract][Full Text] [Related]
8. Apelin-13 protects against cisplatin-induced ototoxicity by inhibiting apoptosis and regulating STAT1 and STAT3. Yin H; Sun Y; Ya B; Guo Y; Zhao H; Zhang L; Wang F; Zhang W; Yang Q Arch Toxicol; 2023 Sep; 97(9):2477-2493. PubMed ID: 37395757 [TBL] [Abstract][Full Text] [Related]
9. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss. Dhukhwa A; Al Aameri RFH; Sheth S; Mukherjea D; Rybak L; Ramkumar V Sci Rep; 2021 Apr; 11(1):8116. PubMed ID: 33854102 [TBL] [Abstract][Full Text] [Related]
10. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect. Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model. Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489 [TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling. Yuan CH; Horng CT; Lee CF; Chiang NN; Tsai FJ; Lu CC; Chiang JH; Hsu YM; Yang JS; Chen FA Environ Toxicol; 2017 Mar; 32(3):845-855. PubMed ID: 27200496 [TBL] [Abstract][Full Text] [Related]
13. Modulating the unfolded protein response with ISRIB mitigates cisplatin ototoxicity. Li J; Rouse SL; Matthews IR; Park Y; Eltawil Y; Sherr EH; Chan DK Sci Rep; 2024 Sep; 14(1):22382. PubMed ID: 39333235 [TBL] [Abstract][Full Text] [Related]
14. Protective Role of Epigallocatechin Gallate in a Rat Model of Cisplatin-Induced Cerebral Inflammation and Oxidative Damage: Impact of Modulating NF-κB and Nrf2. Arafa MH; Atteia HH Neurotox Res; 2020 Feb; 37(2):380-396. PubMed ID: 31410684 [TBL] [Abstract][Full Text] [Related]
15. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity. Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of cisplatin-induced ototoxicity and prevention. Rybak LP; Whitworth CA; Mukherjea D; Ramkumar V Hear Res; 2007 Apr; 226(1-2):157-67. PubMed ID: 17113254 [TBL] [Abstract][Full Text] [Related]
17. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750 [TBL] [Abstract][Full Text] [Related]
18. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity. Jamesdaniel S; Rathinam R; Neumann WL Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies. Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853 [TBL] [Abstract][Full Text] [Related]
20. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase. Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]